Author Correction to: Efficacy and safety of metformin compared to insulin in gestational diabetes: a systematic review and meta-analysis of Chinese randomized controlled trials (International Journal of Clinical Pharmacy, (2022), 44, 5, (1102-1113), 10.1007/s11096-022-01438-z)

Fang Li, Ligang Liu, Yang Hu, Carrie Mc Adam Marx, Wei Liu

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original publication of the article title “systemic” is corrected as “systematic”. The correct title is “Efficacy and safety of metformin compared to insulin in gestational diabetes: a systematic review and meta-analysis of Chinese randomized controlled trials”. The original article has been corrected.

Original languageEnglish (US)
Pages (from-to)283
Number of pages1
JournalInternational Journal of Clinical Pharmacy
Volume45
Issue number1
DOIs
StatePublished - Feb 2023

ASJC Scopus subject areas

  • Pharmacy
  • Toxicology
  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Author Correction to: Efficacy and safety of metformin compared to insulin in gestational diabetes: a systematic review and meta-analysis of Chinese randomized controlled trials (International Journal of Clinical Pharmacy, (2022), 44, 5, (1102-1113), 10.1007/s11096-022-01438-z)'. Together they form a unique fingerprint.

Cite this